GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug development, Ashleigh Furlong of Bloomberg reports. The drugmaker wants the government to invest in linking clinical, genomic, and primary care datasets together and to make them available to researchers and companies. The UK’s Office for Life Sciences is currently working with different funding bodies on the feasibility of the plan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
- Pfizer Stock (PFE) Slips as U.S. Probes the Timing of Its COVID-19 Vaccine Results
- U.S. prosecutors look into claim Pfizer delayed vaccine news, WSJ says
- U.S. to end funding for child vaccines in developing countries, NY Times reports
- Large pharma M&A deals stalling amid volatile policies, Reuters reports